Q Investor Kit January December 2014

Similar documents
Q Investor Kit JANUARY-JUNE 2014

Q Investor Kit JANUARY-MARCH 2014

Q Investor Kit JANUARY-JUNE 2013

Q Investor Kit JANUARY-MARCH 2013

Q2 INVESTOR KIT JANUARY-JUNE 2011

Q Investor Kit January December 2015

SWEDISH MATCH INVESTOR KIT Q4 2016

SWEDISH MATCH RESULTS PRESENTATION Q4 2018

SWEDISH MATCH RESULTS PRESENTATION Q3 2017

Lars Dahlgren. President and CEO

COMPANY PRESENTATION 2017

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes

Summary of Results for the First Half of FY2015/3

Telekom Austria Group Results for the 1st Quarter May 27, 2003

Third-quarter results 2013

RAI: Strong key-brands performance delivers 2Q13 profit growth; Company reaffirms full-year EPS guidance

Hyundai Motor Company 1 st Quarter 2011 Business Results. April 28, 2011

Global Smokeless Tobacco Market

Coloplast A/S. Investor presentation 1H 2005/06

THIRD QUARTER REPORT 2011 (UNAUDITED)

VITROLIFE AB (PUBL) NORDEA Small & Mid Cap Seminar

For personal use only

Annual General Meeting of Shareholders of Philip Morris ČR a.s. Kutná Hora April 27, 2018

VITROLIFE AB (PUBL) Pareto Securities Health Care Conference

Annual General Meeting of Shareholders of Philip Morris ČR a.s. Kutná Hora April 25, András Tövisi Chairman of the Board of Directors

Endesa 1Q 2017 Results 09/05/2017

Forward Looking Information

RAI reports strong 2Q16 performance and positive outlook; Accelerates returns to shareholders

Interim report Second quarter 2017 and subsequent events (Unaudited)

Altria Group Inc. Ticker: MO

DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM

RAI increases 3Q13 earnings on strong operating performance; tightens full-year EPS guidance

DELICA D:5 ACTIVE GEAR 0

CPH Chemie + Papier Holding AG. Investor Day. Perlen, 13 th September 2018

JT Group Consolidated Financial Results 2018 First Quarter Results

For personal use only

Increase in revenues in line with full-year targets (+1.2%) Very strong growth of Oralair exc. USA (+26%) H revenues and results - 24 July 2014

Presentation of. Burgdorf, 1 st November 2012

Reynolds American to Acquire Lorillard

FY2007 Consolidated Financial Overview

Altria Group Inc (MO-NYSE)

FIRSTQUARTER2018 RESULTSPRESENTATION

WntResearch. 100% one-week return? 16 October 2017 PRICE EXPECTATIONS INVESTMENT CASE PRICE TRIGGERS PRICE 12 MONTHS COMPANY PROFILE

CENTRALE. Monetary. compared. domestic. million.

KAPITALMARKNADSDAG 20 SEPTEMBER Thomas Axelsson, CEO

Interim Report 1 January September 2017

Welcome to LG Electronics

TELECONFERENCE Q August 2015

Slide 1. Financial update and closing remarks. Jesper Brandgaard EVP and CFO. RAFAEL DE JESÚS FLORES, Mexico Rafael has haemophilia A

PhotoCure ASA Presentation First quarter 2005 May 3, 2005

Enel Américas 1Q 2018 results

Report for the fourth quarter of 2016 and subsequent events (Un-audited)

BALCHEM CORPORATION. Q Investor Relations Presentation

GN Store Nord Goldman Sachs European Medtech and Healthcare Services Conference. CEO GN ReSound, Mike van der Wallen September 3, 2008

Walgreen Co. Reports Second Quarter 2010 Earnings Per Diluted Share of 68 Cents; Results Include 2 Cents Per Diluted Share of Restructuring Costs

First Quarter Results to March 31, Shire plc April 25, 2008

METVIX PDT ON THE MARKET IN GERMANY AND UK

Slide 1. Investor presentation. London 5 February 2019

Walgreens (WAG) Analyst: Juan Fabres Fall 2014

Leading Intimate Healthcare. Investor presentation Q1 2007/08

Leading Intimate Healthcare

ELICA 2012 Q3 RESULTS. November 14,

An exciting combination in a high growth, high margin Nutrition category. Name of chairman

FY2009 First Quarter Financial Results. SUZUKI MOTOR CORPORATION August 3, 2009

SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS

YEAR END REPORT. September 2013 August Diamyd Medical AB (publ), Fiscal year 2013/2014

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014

Presentation First quarter 2006

Consolidated: Financial Summary

Asia Illicit Tobacco Indicator 2016: Pakistan. Prepared by Oxford Economics November 2017

Investor Day Lausanne, September 27, 2018

Forward-Looking Statements

WntResearch. Pearls on a string. 3 September 2018 PRICE EXPECTATIONS INVESTMENT CASE PRICE TRIGGERS PRICE 12 MONTHS COMPANY PROFILE

Aerpio Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

JT Reports Consolidated Financial Results For the Nine-Month Period that Ended December 31, 2007

(LO-NYSE) SUMMARY. Risk Level *

ASL MARINE. DBS Vickers Pulse of Asia Roadshow 10 January 2012

ADM to Acquire Neovia and Probiotics International Limited. July 2, 2018

Imperial Brands Maximising Category Opportunities CAGNY February 2019

PhotoCure ASA. Presentation. Results 1 Quarter 2004

SNUS ON THE LOOSE: Big Tobacco s s latest attempt to make nicotine more attractive

Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical

Group financial results for the first quarter 2008

Valneva Reports Strong Q1 Revenue Growth and Positive EBITDA Reaffirms Financial Guidance and Pipeline Outlook for 2017

Straumann s net revenues reach CHF 185 million in Q1, driven by continuing double-digit growth in America

ThromboGenics Business Update H1 2018

Coloplast A/S. Investor Presentation 2005/06

1Q 2009 Results Presentation. 12 May 2009

Investor Presentation June 2012 NASDAQ: CEMI

A GLOBAL LEADER IN PERSONALIZED NUTRITION

2014 CAGNY Investor Presentation. February 19, 2014

Closing of Nucletron acquisition Building a stronger position in the cancer care market. September 15, 2011

chapter 9 Burden of Tobacco

Morgan Stanley Global Consumer & Retail Conference New York, November 19, 2014

Growth in core businesses offsets weaker non-interest income. DBS Group Holdings 1Q 2005 Financial Results Presentation to Media and Analysts

1Q 2014 Earnings Release

BANK HANDLOWY W WARSZAWIE S.A. 1Q 2009 consolidated financial results -1-

ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update

Designing a Smoke-Free Future

Slide 1. International Operations update. Mike Doustdar EVP International Operations. YASMIN FIEDLER, Germany Yasmin has type 1 diabetes

Transcription:

Q4 2014 Investor Kit January December 2014

Highlights for Q4 Sales up for all product areas and operating profit from product areas up by 8% Scandinavian hoarding for snus prior to tax increase in January 2015 Both hoarding and calendar effects in Sweden and Norway improved the quarterly result. Continued market share growth in Swedish snus value priced segment* Swedish Match now holds close to 40% of Swedish value priced segment. Value priced products represent an increasing share of Swedish Match volume, negatively impacting average selling prices and margins. Cigar sales and volumes up, led by natural leaf products Strong volume growth, partly on comparably soft volume in Q4 2013. Less pronounced decline of average price per cigar vs previous quarters. End of US tobacco quota buy-out program fees More than 1 MUSD of positive impact for Other tobacco products. No change in status on FDA for MRTP or cigar regulation Solid performance for Lights despite volume declines Positive pricing, but geopolitical uncertainty affected volume development. Currency impacts primarily from stronger USD * Swedish Match s own estimates. Nielsen does not segment the market as premium vs. value. 2

Sales performance for Q4 and full year Increased sales The fourth quarter Sales increased by 11% to 3,536 MSEK (3,178). In local currencies, sales were 7% higher. The full year Sales increased by 6% to 13,305 MSEK (12,610). In local currencies, sales were 4% higher. Snus and moist snuff product area: sales up The fourth quarter Sales up 6%, and up 3% in local currencies. Scandinavian sales up, but excluding hoarding/calendar effects was down. US sales up for both moist snuff and snus. The full year Sales up 3%, and up 2% in local currencies, helped by yearend hoarding/calendar effects in Scandinavia. US sales up for both moist snuff and snus. Other tobacco products product area: sales up, driven by higher volumes for cigars The fourth quarter Sales up 23%, and up 7% in local currency. The full year Sales up 10%, and up 5% in local currency. Lights product area: sales up in Q4, down for full year The fourth quarter Sales up 5%, driven by higher average prices for matches, more than offsetting lower volumes. The full year Sales down 3%, driven by lower volumes for lighters. 3

Operating profit performance for Q4 and full year Operating profit higher The fourth quarter Operating profit from product areas up 8%, and up 4% in local currencies Operating profit including STG up 6% to 992 MSEK (932). The full year Operating profit from product areas up 2%, and up 1% in local currencies Operating profit including STG up 2% to 3,780 MSEK (3,693). Snus and moist snuff product area: profits up The fourth quarter Operating profit up 3%, up 3% in local currencies. In Scandinavia operating profit was down when taking into account hoarding/calendar effects. US moist snuff operating profits up. The full year Operating profit up 1%, up 1% in local currencies. In Scandinavia operating profit down, adjusting for hoarding/calendar effects and restructuring charges in Q3 2013. US moist snuff operating profits up. International snus investments: higher than prior year for both fourth quarter and full year. Other tobacco products product area: profits up The fourth quarter Operating profit up 26%, up 12% in local currency, with higher profits from cigars. The full year Operating profit up 8%, up 3% in local currency, with higher profits from both cigars and chewing tobacco. Lights product area: profits down in local currencies Operating profit flat in Q4, and down 5% for the full year. 4

Other events following Q4 results Pricing in Sweden post tax increase Price increases (either through higher consumer prices or lower weights) for many products, broadly in line with tax increases. Norway proposal for standardized packaging and product information Final draft soon to be circulated for commentary. Tax rate Group tax rate expected to go up in 2015 to a large extent as a consequence of a stronger USD. Scandinavian Tobacco Group Niels Frederiksen, who is currently EVP of Global Supply Chain and on STG s Executive Board, appointed CEO effective as of March 1, 2015. Shareholders of STG, while keeping all options open, will focus on exploring a potential initial public offering. 5

Sales and operating profit Sales and operating profit by product area Q4 2014 Full year 2014 Sales, SEK Operating profit*, SEK Sales, SEK Operating profit*, SEK 7% 6% 32% 10% 20% 37% 31% 62% 31% 10% 21% 38% 31% 62% Snus and moist snuff Other tobacco products Lights Other operations Snus and moist snuff Other tobacco products Lights Other operations * Excluding Other operations, share of net profit in STG and larger one-time items. Totals may not add up due to rounding. 6

Sales by currency block Percent of sales, MSEK Q4 2014 Full year 2014 13% 12% SEK USD 30% 58% All other* 31% 57% Excluding Other operations SEK USD All other* 19% 38% 17% 38% 44% 45% * Primarily NOK and BRL. Totals may not add up due to rounding. 7

Snus and moist snuff Leading position for snus in Scandinavia The third largest producer of moist snuff in the US General is the second largest and fastest growing snus brand in the US Production in Sweden and the US Joint venture with Philip Morris International for markets outside Scandinavia and the US 8

Snus and moist snuff (Q4 commentary) Hoarding in Scandinavia, and growing share in Swedish value segment Scandinavia snus sales up, helped by hoarding/calendar effects Higher volumes largely due to hoarding/calendar effects but also higher on an underlying basis. Sales down when backing out hoarding/calendar effects on lower average portfolio pricing, stemming from higher proportion of value priced products and price reduction on Kronan. Operating profit lower when excluding hoarding/calendar effects due to mix shifts. Gaining share of growing Swedish value segment*. US moist snuff sales and operating profit up Moist snuff sales and operating profit in USD were higher due to improved realized pricing. Volumes down largely due to promotional phasing. Continued investment behind snus internationally (incl. US) Snus sales in the US up, with higher year on year shipment volumes, and on price/mix. In total, net costs of snus expansion outside Scandinavia was 100 MSEK (85) impacted by the stronger USD. * Price segmentation using Swedish Match estimates. MSEK Q4-2014 Q4-2013 chg Full year 2014 Full year 2013 Sales 1,323 1,247 6 5,001 4,868 3 Operating profit 577 562 3 2,207 2,195 1 Operating margin, % 43.6 45.1 44.1 45.1 chg 9

Scandinavian market growth and share estimates Scandinavian snus market up approximately 5% in 2014* Swedish market up close to 5% in 2014 and by more than 3% in Q4.* Norwegian market up approximately 8% in 2014 and up by more than 6% in Q4.* Swedish Match s market shares** Percent October-December Chg Full year Chg 2014 2013 ppts 2014 2013 ppts Snus, Sweden, total 69.4 70.8-1.4 69.9 72.2-2.3 Snus, Sweden, premium 94.0 95.1-1.1 94.0 95.3-1.3 Snus, Sweden, value 39.1 35.9 3.2 38.1 36.7 1.4 Snus, Norway, total 58.8 62.5-3.7 60.1 63.6-3.5 * Source: Swedish Match estimates. ** Swedish Match estimates using Nielsen data (excl. tobacconists due to small sample of tobacconists in Nielsen data).12 weeks and YTD to December 28, 2014. 10

Moist snuff market growth and share estimate US moist snuff market up by 1-2% in 2014 versus year ago* Some slowdown in growth in recent months. Category growth continues to be driven by the value segment and pouches. Swedish Match moist snuff market share in the US Swedish Match estimates its market share based on industry shipments to be approximately 9% of the market in 2014. * Source: Swedish Match and industry estimates. 11

Manufacturer share by price segment, Sweden Total volume shares 0,8% 7,2% Swedish Match Competitor 1 Competitor 2 Competitor 3 Other 14,8% 8,0% 69,3% January 25, 2015 (4 weeks ending), Swedish Match share of: Premium segment was: 94.2% Value segment was: 39.6% Total market was: 69.2% Share of premium segment 3,9% 0,5% 1,6% Share of value segment 1,2% 15,9% 39,3% 28,0% 94,0% 15,7% Source: Nielsen (excluding tobacconists), 12 weeks ending January 25, 2015. 12

Estimated snus consumption, Scandinavia Million cans 360 320 280 240 200 160 120 80 40 0 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013* 2014 Source: Swedish Match estimates, adjusted for hoarding in Sweden. * 2013 figure rebased. 13

US moist snuff category development Category by segment*: premium vs. value Million cans 1 500 1 400 1 300 1 200 1 100 1 000 900 800 700 600 500 400 300 200 100 0 196 257 336 405 473 540 587 640 711 812 889 939 616 614 588 588 595 607 583 626 603 562 541 520 2003 2004 2005 Premium 2006 2007 2008 Price value 2009 2010 2011 2012 2013 2014 * Estimates have been restated by Swedish Match using industry reports and distributor shipments to retail. 14

US moist snuff category development Category by segment*: loose vs. pouches Million cans 1 500 1 400 1 300 1 200 1 100 1 000 900 800 700 600 500 400 300 200 100 0 30 782 35 42 836 882 50 943 Loose Pouches 169 190 144 125 114 75 92 61 1007 1072 1078 1152 1189 1230 1261 1269 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 * Estimates have been restated by Swedish Match using industry reports and distributor shipments to retail. 15

Snus expansion outside Scandinavia Snus in the US Continued investments for future growth High level of consumer engagement activities. Market share continued to grow versus prior year Consumption growth for General, faster than market growth rate. General is the number two selling brand of snus in the US. Snus sales up year on year in Q4 Gross shipments and net shipments were up in Q4 vs. prior year. Lower level of pipeline for new store expansion in 2014 than in 2013. SMPM International Test markets continue 16

Other tobacco products US cigars Swedish Match is a major player in the US (mass market) cigar market Production takes place in Santiago, Dominican Republic and Dothan, Alabama Chewing tobacco Nearly all chewing tobacco sales are in the US. Swedish Match is the largest producer and production takes place in Owensboro, Kentucky 17

Other tobacco products (with Q4 commentary) Cigar volume growth, driven by natural leaf cigars In local currency, sales were up 7% while operating profit was up 12% Cigars sales and operating profit up on higher volumes Positive impact on operating profit from higher sales and elimination of tobacco buy-out quota fee. Cigar volumes up 16%, partly as a result of soft volumes in the prior year period. Continued strong volume development of Game by Garcia y Vega natural leaf cigars. Volume growth for Jackpot brand (launched in H2 2013). Chewing tobacco sales and operating profit up in SEK, down in local currency Volume declines of 10% for own products, affected by promotional phasing. Sales and operating profit declined less than volumes in percent due to favorable pricing. MSEK Q4-2014 Q4-2013 chg Full year 2014 Full year 2013 Sales 723 590 23 2,832 2,564 10 Operating profit 288 228 26 1,109 1,029 8 Operating margin, % 39.8 38.6 39.2 40.1 chg 18

Other tobacco products Shipment volumes for cigars and chewing tobacco October- December chg Full Year chg 2014 2013 % 2014 2013 % Cigars, millions of sticks 266 229 16 1,127 1,003 12 Chewing tobacco, thousands of pounds (excl. contract manufacturing) 1,732 1,930-10 7,856 8,260-5 19

Lights (with Q4 commentary) Asia lighter volume growth and price/mix improvement for matches Swedish Match is market leader in many markets. The brands are mostly local and hold a strong position in their respective markets Main markets EU, Brazil, Asia and East Europe Sales up, operating profit flat on volume declines for matches and lighters Strength in lighters in Asia, weakness in Russia and some European markets Improved sales performance in Brazil Higher sales for both matches and lighters, as well as for complementary products. Production in Brazil, the Netherlands, the Philippines and Sweden MSEK Q4-2014 Q4-2013 chg Full year 2014 Full year 2013 Sales 362 345 5 1,295 1,332-3 Operating profit 63 63 0 218 230-5 Operating margin, % 17.3 18.1 16.8 17.3 chg 20

Scandinavian Tobacco Group (STG) fourth quarter STG sales up 10% Adjusted for currency translation effects and the Verellen acquisition, sales up 3%. Gross profit up driven by higher result from all product areas except for pipe tobacco Machine made cigar sales and gross profit up, with prior year negatively affected by destocking. Handmade cigar sales and gross profit up on higher volumes and positive mix effects. Fine cut tobacco sales and gross profit up on positive country mix. Pipe tobacco sales and gross profit down on lower volumes partly affected by timing. Operating expenses increased as a result of costs for the integration of Verellen and currency effects Prior year was negatively affected by personnel related restructuring charges. Reported EBITDA amounted to 313 MDKK (289) Total STG net finance cost amounted to 14 MDKK (31) The decline was explained by exchange gains this quarter. Net profit for STG amounted to 152 MDKK (176) Net profit in 2013 included a non-recurring positive adjustment to income taxes, relating to a change in the legal structure of the group. Swedish Match share of STG net profit after interest and tax amounted to 92 MSEK (97) Niels Frederiksen appointed new CEO as of March 1, 2015. 21

Tax, cash flow and financing (Full year) Tax rate for the Group was 19.7% Includes profit and loss impact from associated companies. The reported tax rate, excluding one-time items, associated companies, and joint ventures was 22% (21). Cash flow Cash flow from operating activities for the year was 3,276 MSEK (2,500), positively affected by timing of cash flow from changes in working capital. Net cash flow from investment activities amounted to 274 MSEK (240). The cash from investment activities in prior year was affected positively by the proceeds from the sale of a parcel of land. Cash distributed to shareholders Dividend distributed to shareholders amounts to 1,453 MSEK. Shares to an amount of 890 MSEK have been repurchased. This represents 3.7 million shares at an average price of 237.59 SEK. In total 2,343 MSEK have been distributed to shareholders via dividend and share buy-backs. 22

Tax, cash flow and financing (Full year) Financial policy Dividend policy: 40-60% of earnings per share. 2014 dividend: 7.50 SEK per share (7.30). Net debt not to exceed 3 times EBITA*. Financing The net finance cost amounted to 510 MSEK (544), down by 34 MSEK mainly due to lower interest bearing debt. Higher level of net retirement benefit obligations on lower discount rates, currencies, and demographic assumptions, and amounted to 1,734 MSEK (1,044) The interest bearing debt excluding retirement benefit obligations amounted at December 31, 2014 to 8,703 MSEK. Cash and cash equivalents amounted at December 31, 2014 to 2,312 MSEK. Net debt/ebita per December 31, 2014 was at 2.3*. * Excluding share of net profit in STG. Operating profit adjusted for amortization and write-downs of intangible assets. 23

Maturity profile of interest bearing liabilities As of December 31, 2014 MSEK 3 500 3 000 2 500 2 000 1 500 Fixed Float 1 000 500 0 2015 2016 2017 2018 2019 2022 2023 2028 Year 24

P&L in summary MSEK Q4-2014 Q4-2013 Chg % Full year 2014 Full year 2013 Sales 3,536 3,178 11 13,305 12,610 6 Cost of goods sold -1,910-1,698-7,109-6,647 Gross profit 1,627 1,481 10 6,197 5,963 4 Selling and administrative expenses -710-633 -2,703-2,556 Share of profit/loss in associated companies and joint ventures 75 84 285 287 Capital gain from sale of land - - - 161 Operating profit 992 932 6 3,780 3,855-2 Finance income 5 9 27 34 Finance costs -137-137 -537-578 Net finance cost -132-128 -510-544 Profit before income tax 861 804 7 3,270 3,310-1 Income tax expense -161-128 -644-600 Profit for the period 700 675 4 2,626 2,711-3 EPS, basic, SEK, incl. larger one-time items 3.55 3.43 13.23 13.63 EPS, basic, SEK, excl. larger one-time items 3.55 3.43 13.23 12.82 EPS, diluted, SEK, incl. larger one-time items 3.55 3.43 13.22 13.61 EPS, diluted, SEK, excl. larger one-time items 3.55 3.43 13.22 12.80 Chg % 25

Balance sheet in summary MSEK December 31, 2014 December 31, 2013 Intangible assets 1,030 973 Property, plant and equipment 2,074 2,027 Investments in associated companies and joint ventures 5,233 4,506 Other non-current financial receivables* 1,669 1,165 Current operating assets 4,255 3,038 Other current investments and current financial assets* - 8 Cash and cash equivalents 2,312 3,164 Total assets 16,573 14,881 Equity attributable to equity holders of the Parent 277-786 Non-controlling interests 1 1 Total equity 279-785 Non-current provisions 1,081 1,031 Non-current loans 7,803 9,420 Other non-current financial liabilities* 2,063 1,440 Current provisions 98 103 Current loans 1,141 920 Other current liabilities* 4,109 2,751 Total equity and liabilities 16,573 14,881 * For full detail, please refer to notes in the January-December 2014 report. 26

Cash flow in summary MSEK Jan-Dec 2014 Jan-Dec 2013 Cash flow from operating activities before changes in working capital 2,893 2,820 Cash flow from changes in working capital 384-320 Net cash from operating activities 3,276 2,500 Purchase of property, plant and equipment -223-306 Proceeds from sale of property, plant and equipment 2 0 Purchase of intangible assets -5-35 Acquisition of subsidiaries -2 - Investments in associated companies and joint ventures* -45-57 Proceeds from sale of subsidiaries, net of cash disposed of* - 158 Changes in financial receivables etc. 0 0 Net cash used in investing activities -274-240 Changes in loans -1,802-277 Dividend paid to equity holders of the Parent -1,453-1,459 Repurchase of own shares -890-352 Stock options exercised 53 187 Other 4-12 Net cash used in financing activities -4,088-1,912 Net increase in cash and cash equivalents -1,085 348 Cash and cash equivalents at the beginning of the period 3,164 2,824 Effect of exchange rate fluctuations on cash and cash equivalents 232-8 Cash and cash equivalents at the end of the period 2,312 3,164 * For full detail, please refer to notes in the January-December 2014 report. 27

Key ratios* MSEK * All key ratios, unless otherwise stated, have been calculated excluding larger one-time items. ** For full detail, please refer to notes in the January-December 2014 report. Jan-Dec 2014 Jan-Dec 2013 Operating margin, % 28.4 29.3 Operating capital, MSEK 8,314 7,729 Return on operating capital, % 47.1 49.3 EBITDA, MSEK** 4,083 3,968 EBITA, MSEK** 3,821 3,725 Net debt, MSEK 8,126 8,388 Net debt/ebita** 2.1 2.3 Investments in property, plant and equipment, MSEK** 223 306 EBITA interest cover 7.6 7.0 Excluding share of net profit in STG EBITA, MSEK** 3,487 3,406 Net debt/ebita** 2.3 2.5 Share data EPS, basic, SEK, incl. larger one-time items 13.23 13.63 EPS, basic, SEK, excl. larger one-time items 13.23 12.82 EPS, diluted, SEK, incl. larger one-time items 13.22 13.61 EPS, diluted, SEK, excl. larger one-time items 13.22 12.80 Shares outstanding, end of period (Mio) 195.7 199.0 Average number of shares outstanding, basic (Mio) 198.5 198.9 28

Largest shareholders* As per December 31, 2014 Largest shareholders Didner & Gerge Funds 3.5% Standard Life Investment Funds 3.4% Nordea Funds 2.8% SEB Funds 2.3% Second Swedish National Pension Fund 2.0% SHB Funds 1.6% Fourth Swedish National Pension Fund 1.3% Govt of Singapore Inv Corp 1.0% UBS (Lux) Funds 1.0% Third Swedish National Pension Fund 0.8% 19.7% 47,952 shareholders Outside Sweden 71% Sweden 29% Source: Euroclear, official registry and SIS Ägaranalys. * Percent split of share capital held, excluding Swedish Match shares held in treasury. 29

Comparable sales Excluding businesses transferred to STG (MSEK) CAGR 09-14 Other operations Lights Other tobacco products Snus and moist snuff 10,678 2,689 1,403 2,337 * 11,222 2,831 1,429 2,440 * 11,666 3,206 1,346 2,388 +4% 12,486 3,437 1,339 2,661 12,610 3,847 1,332 2,564 13,305 4,178 1,295 2,832 9% -2% 4% 3% 4,250 4,522 4,726 5,049 4,868 5,001 3% 2009 2010 2011 2012 2013 2014 30

Comparable operating profit Excluding businesses transferred to STG (MSEK) CAGR 09-14 2,900 312 804 3,158 279 942 3,365 240 1,049 +4% 3,666 222 1,161 3,375 230 1,029 3,446 218 1,109 Other operations Lights Other tobacco products Snus and moist snuff -7% 7% 3% 1,916 * * 2,080 2,181 2,349 2,195 2,207 3% -132-142 -105-65 -80-88 2009 2010 2011 2012 2013 2014 31

Snus vs. cigarettes in Sweden Volume of snus and cigarettes in Sweden 1916-2013 Cigarettes (million packs) 700 630 560 490 420 350 280 210 140 70 0 Cigarettes Snus Snus (million cans) 250 225 200 175 150 125 100 75 50 25 0 Adjusted for estimated snus hoarding 1996, 1997, 2006, 2007, 2008, 2011 and 2012. Source: Swedish Match Distribution AB and Swedish Match estimates. 32